News

Shares of Johnson & Johnson and Amgen are trading lower Wednesday morning, sending the Dow Jones Industrial Average into negative territory. Shares of Johnson & Johnson and Amgen are contributing to ...
One big reason the Dow Jones Industrial Average slipped Tuesday had little to do with tariffs. Johnson & Johnson's stock ...
The Dow Jones Industrial Average is down Tuesday afternoon with shares of Johnson & Johnson and Merck seeing the biggest drops for the price-weighted average. Supported by world-class markets data ...
Tim Smith has 20+ years of experience in the financial services industry, both as a writer and as a trader. Johnson & Johnson shares tumbled Tuesday to lead S&P 500 decliners after the health ...
--Down 6.49% from its 52-week closing high of $167.70 on March 10, 2025 --Up 10.39% from its 52-week closing low of $142.06 on Jan. 10, 2025 --Traded as low as $156.80; lowest intraday level since ...
The Dow Jones Industrial Average was down 1,200 ... “Beyond the market meltdown, the bigger concern is the impact and potential crises for small and trade-dependent economies, so it’s crucial ...
Dow Jones moved lower as Johnson & Johnson pulled back by 7%. The stock suffered a sell-off as a bankruptcy judge rejected talc settlement. The talc lawsuit is an important catalyst for the ...
Johnson & Johnson's decision does not impact Genmab's 2025 financial guidance, it said. Write to Katherine Hamilton at [email protected] About Dow Jones Newswires Dow Jones Newswires is a ...
In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Hold rating on Johnson & Johnson (JNJ – Research Report), with a price target of $152.00. The company’s shares ...
Volatility is often measured by the Chicago Board Options Exchange's CBOE Volatility Index. Experts currently expect volatility in the markets to persist, as few expect this week to mark the end of ...